JP Morgan highlights mixed sentiment for U.S. large-cap biopharma stocks as advancements in obesity drugs and key product launches shape 2025 outlook. Galapagos NV plans to split into two entities ...
The stock's fall snapped a two-day winning streak.
Deepseek logo and rising stock graph are seen in this illustration taken, January 27, 2025. REUTERS/Dado Ruvic/Illustration/File Photo ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback